BioLineRx (BLRX) EBITDA Margin (2018 - 2026)
BioLineRx (BLRX) recorded EBITDA Margin of -1188.78% in the quarter ended Jun 30, 2026, down 431.21 percentage points from -757.57% a year earlier.
Powered by 
Analysis
BioLineRx (BLRX) EBITDA Margin (2018 - 2026) Analysis & Trends
On a TTM basis, BioLineRx's EBITDA Margin came in at -969.81% as of Jun 30, 2026, down 902.28 percentage points year-over-year; for the year ended Dec 31, 2025, it came in at -827.46%, down 770.99 percentage points from the prior year.
- Across earlier years, EBITDA Margin came in at -56.47% in the year ended Dec 31, 2024 (+949.99 pp) and -1006.46% in the year ended Dec 31, 2023.
- Quarterly EBITDA Margin has ranged from -1712.89% in the quarter ended Dec 31, 2025 to -21.91% in the quarter ended Dec 31, 2024 over the past five years.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.06 Bn | 1,102.65 Bn | 19.71 Bn | 53.49% |
| 2 | Johnson & Johnson | 616.49 Bn | 535.01 Bn | 17.26 Bn | 35.95% |
| 3 | AbbVie | 501.55 Bn | 474.66 Bn | 12.70 Bn | 49.01% |
| 4 | Merck | 367.24 Bn | 321.62 Bn | 12.21 Bn | 6.02% |
| 5 | Novartis Ag | 297.99 Bn | 261.98 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.48 Bn | 235.17 Bn | 12.86 Bn | 33.11% |
| 7 | Amgen | 236.17 Bn | 191.57 Bn | 7.24 Bn | 46.01% |
| 8 | Gilead Sciences | 190.68 Bn | 164.87 Bn | 6.22 Bn | -124.26% |
| 9 | Pfizer | 169.35 Bn | 115.99 Bn | 10.94 Bn | 39.16% |
| 10 | BioLineRx | 8.67 Mn | -67.85 Mn | 235,000.00 | -1,188.78% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,188.78% |
| Dec 31, 2025 | -1,712.89% |
| Sep 30, 2025 | -488.99% |
| Jun 30, 2025 | -699.67% |
| Mar 31, 2025 | -872.94% |
| Dec 31, 2024 | -21.91% |
| Sep 30, 2024 | -91.99% |
| Jun 30, 2024 | -98.22% |
| Mar 31, 2024 | -57.26% |
| Sep 30, 2021 | -1,833.33% |
| Mar 31, 2021 | -1,343.62% |
| Sep 30, 2020 | -698.90% |
| Mar 31, 2020 | -1,423.36% |
| Sep 30, 2019 | -785.19% |
| Mar 31, 2019 | -892.68% |
| Sep 30, 2018 | -55,327.27% |
API Access
BioLineRx EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=BLRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "BLRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=BLRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();